Sanjiv Sam Gambhir, MD, PhD
Publication Details
-
F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Clin Nucl Med. 2006; (12): 754-60
Osseous and soft tissue sarcomas (OSTS) represent a histologic heterogeneous group of malignant tumors. Most of the current clinical data on the role of F-18 FDG PET in sarcomas come from patients studied with dedicated PET and less frequently with hardware fusion PET/CT. Therefore, we were prompted to review our experience with F-18 FDG PET/CT in OSTS.
Help
Trial Administration